DAM
ITCI

DLD Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

DLD Asset Management’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-202,000
Closed -$1.51M – 104
2019
Q3 		$1.51M Sell
202,000
-950,900
-82% -$9.12M 0.08% 60
2019
Q2 		$14.9M Sell
1,152,900
-350,200
-23% -$4.49M 0.62% 30
2019
Q1 		$18.3M Sell
1,503,100
-725,400
-33% -$9.27M 0.67% 28
2018
Q4 		$25.4M Buy
2,228,500
+900,200
+68% +$14.5M 1.74% 19
2018
Q3 		$28.8M Buy
1,328,300
+169,000
+15% +$3.53M 1.42% 15
2018
Q2 		$20.5M Buy
1,159,300
+138,300
+14% +$2.81M 1.54% 14
2018
Q1 		$21.5M Buy
1,021,000
+598,300
+142% +$11.7M 1.94% 15
2017
Q4 		$6.12M Buy
+422,700
New +$6.53M 0.44% 33

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return